Emergent BioSolutions
EBS
#6766
Rank
S$0.82 B
Marketcap
S$15.42
Share price
-1.24%
Change (1 day)
25.91%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of September 2025 : S$1.89 Billion

According to Emergent BioSolutions 's latest financial reports the company's total assets are S$1.89 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$1.88 B-21.55%
2023-12-31S$2.40 B-43.27%
2022-12-31S$4.24 B6.16%
2021-12-31S$3.99 B4.83%
2020-12-31S$3.81 B21.57%
2019-12-31S$3.13 B3.02%
2018-12-31S$3.04 B112.78%
2017-12-31S$1.43 B1.95%
2016-12-31S$1.40 B-4.33%
2015-12-31S$1.46 B18.32%
2014-12-31S$1.24 B56.23%
2013-12-31S$0.79 B15.06%
2012-12-31S$0.68 B-2.57%
2011-12-31S$0.70 B9.89%
2010-12-31S$0.64 B33.18%
2009-12-31S$0.48 B16.36%
2008-12-31S$0.41 B5.66%
2007-12-31S$0.39 B7.73%
2006-12-31S$0.36 B118.7%
2005-12-31S$0.16 B48.28%
2004-12-31S$0.11 B
2002-12-31S$39.54 M-15.98%
2001-12-31S$47.06 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
S$167.87 B 8,766.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
S$0.30 B-84.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.86 B 5,544.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$0.84 B-55.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 14,186.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.64 B 2,627.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
S$14.63 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA